Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 24,386,536 | 24,386,536 | - | - | Class B Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 24,386,536 | 24,386,536 | - | - | Common Units | |
| Whitehawk Therapeutics Inc | Behzad Aghazadeh | Director, Ten Percent Owner, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 8,333,000 | 8,333,000 | - | - | Pre-funded Warrant (right to buy) | |
| Resolute Holdings Management Inc | Thomas R. Knott | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,107,534 | 4,107,534 | - | - | Common Stock, par value $0.0001 per share | |
| Resolute Holdings Management Inc | John D. Cote | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 4,107,534 | 4,107,534 | - | - | Common Stock, par value $0.0001 per share | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,155,188 | 2,155,188 | - | - | Class B Common Stock | |
| TKO (Class A) | Ariel Z. Emanuel | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,155,188 | 2,155,188 | - | - | Common Units | |
| Nuvation Bio Inc (Class A) | David T. Hung | Director, PRESIDENT AND CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 2,000,000 | 2,000,000 | - | - | Stock Option (Right to Buy) | |
| Clear Channel Outdoor Holdings Inc | W. Benjamin Moreland | Director | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 28 Feb 2025 | 800,000 | 2,510,821 (4%) | 1% | 1.3 | 1,008,000 | Common Stock |
| fuboTV Inc | David Gandler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 782,358 | 782,358 | - | - | Restricted Stock Units | |
| Semileds Corp | Scott Simplot | Director, Ten Percent Owner | Other type of transaction at price $ 1.66 per share. | 28 Feb 2025 | 722,891 | 3,199,226 (88%) | 20% | 1.7 | 1,199,999 | Common Stock |
| CNH Industrial NV | Gerrit Andreas Marx | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 695,608 | 494,012 | - | - | Restricted Share Units | |
| CNH Industrial NV | Gerrit Andreas Marx | Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 695,608 | 695,608 (7%) | 7% | - | Common Shares | |
| Olema Pharma Inc | Sean P. Bohen | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 650,000 | 650,000 | - | - | Stock Option (Right to Buy) | |
| Phillips Edison & Co Inc - Ordinary Shares - New | Jeffrey S. Edison | Director, Chairman and CEO | Other type of transaction at price $ 0.00 per share. | 28 Feb 2025 | 610,000 | 1,814,405 | - | - | OP Units | |
| Phillips Edison & Co Inc - Ordinary Shares - New | Jeffrey S. Edison | Director, Chairman and CEO | Other type of transaction at price $ 0.00 per share. | 28 Feb 2025 | 610,000 | 1,976,004 | - | - | OP Units | |
| American Axle & Manufacturing Holdings Inc | David C. Dauch | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 605,264 | 1,690,388 (1%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 7.92 per share. | 28 Feb 2025 | 500,000 | 9,929,500 (11%) | 0% | 7.9 | 3,960,000 | Common Shares |
| Nuvation Bio Inc (Class A) | Kerry Wentworth | CHIEF REGULATORY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Gary Hattersley | CHIEF SCIENTIFIC OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Stacy Markel | CHIEF PEOPLE OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | David C. Hanley | CHIEF TECHNICAL OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Dongfang Liu | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Colleen Sjogren | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Philippe Sauvage | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (Right to Buy) | |
| Prime Medicine Inc | Keith Gottesdiener | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 500,000 | 500,000 | - | - | Stock Option (right to buy) | |
| Coupang Inc (Class A) | Gaurav Anand | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 480,490 | 2,417,990 | - | 0 | Class A Common Stock | |
| Sinclair Inc (Class A) | Christopher S. Ripley | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 465,671 | 683,045 (1%) | 0% | - | Class A Common Stock | |
| Olema Pharma Inc | Shawnte M. Mitchell | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 450,000 | 450,000 | - | - | Stock Option (Right to Buy) | |
| Marathon Digital Holdings Inc | Frederick G. Thiel | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 417,550 | 4,328,393 (55%) | 5% | 0 | Common Stock | |
| NextTrip Inc | Donald P. Monaco | Director | 28 Feb 2025 | 413,907 | 745,032 | - | - | Series L Nonvoting Convertible Preferred Stock | ||
| Safe Pro Grp Inc | Daniyel Erdberg | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 400,000 | 5,070,000 | - | - | Common Stock | |
| Aurinia Pharma Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 7.85 per share. | 28 Feb 2025 | 399,280 | 8,828,780 (10%) | 0% | 7.9 | 3,134,348 | Common Shares |
| Warner Bros. (Class A) | Bruce L. Campbell | Chief Rev & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 397,919 | 795,838 | - | - | Employee Stock Option | |
| Warner Bros. (Class A) | Jean-Briac Perrette | Pres.&CEO, Global Streaming | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 397,919 | 397,919 | - | - | Employee Stock Option | |
| Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 396,000 | 396,000 | - | - | Stock Option (right to buy) | |
| Brandywine Realty Trust | Gerard H. Sweeney | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 381,148 | 2,948,865 (1%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Warner Bros. (Class A) | Gunnar Wiedenfels | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 374,512 | 374,512 | - | - | Employee Stock Option | |
| Grocery Outlet Holding Corp | Jason Potter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 371,025 | 371,025 | - | - | Stock Options (Right to Buy) | |
| Intel | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 359,304 | 359,304 | - | - | Restricted Stock Units | |
| Intel | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 359,304 | 359,304 | - | - | Performance Stock Units | |
| Aurinia Pharma Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.02 per share. | 28 Feb 2025 | 351,962 | 9,281,462 (10%) | 0% | 8.0 | 2,822,735 | Common Shares |
| Corcept Therapeutics Inc | Joseph K. Belanoff | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 350,000 | 350,000 | - | - | Stock option (right to buy) | |
| Tetra Technologies Inc | Brady M. Murphy | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 349,692 | 349,692 | - | - | Restricted Stock Units | |
| Accuray Inc | Leonel Peralta | SVP, Chief Operations Officer | 28 Feb 2025 | 334,889 | 334,889 | - | - | Restricted Stock Units | ||
| NextTrip Inc | Donald P. Monaco | Director | 28 Feb 2025 | 331,125 | 745,032 | - | - | Series L Nonvoting Convertible Preferred Stock | ||
| Absci Corp | Zachariah Jonasson | CFO / CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 321,800 | 321,800 | - | - | Stock Option (right to buy) | |
| CNH Industrial NV | Gerrit Andreas Marx | Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 11.64 per share. | 28 Feb 2025 | 320,472 | 375,136 (4%) | 3% | 11.6 | 3,730,294 | Common Shares |
| Olema Pharma Inc | Shane Kovacs | CH. OPERATING & FINANCIAL OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 320,000 | 320,000 | - | - | Stock Option (Right to Buy) | |
| fuboTV Inc | David Gandler | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 308,549 | 308,549 | - | - | Restricted Stock Units | |
| Leggett & Platt Inc | Karl G. Glassman | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 300,372 | 1,444,088 (1%) | 0% | 0 | Common Stock | |
| TeraWulf Inc | Paul B. Prager | Director, Chief Executive Officer | Other type of transaction at price $ 0.00 per share. | 28 Feb 2025 | 300,000 | 500,883 | - | - | Common stock, $0.001 par value per share | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 288,392 | 737,992 (1%) | 0% | - | Class A Common Stock | |
| Warner Bros. (Class A) | Gerhard Zeiler | President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 280,884 | 280,884 | - | - | Employee Stock Option | |
| Marathon Digital Holdings Inc | Salman H. Khan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 274,704 | 1,821,434 (23%) | 3% | 0 | Common Stock | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 270,805 | 911,870 (0%) | 0% | 0 | Common Stock | |
| Grocery Outlet Holding Corp | Jason Potter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 250,000 | 250,000 | - | - | Stock Options (Right to Buy) | |
| Nuvation Bio Inc (Class A) | Moses Makunje | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 250,000 | 250,000 | - | - | Stock Option (Right to Buy) | |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 245,000 | 1,736,046 (0%) | 0% | 0 | Common Stock | |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 245,000 | 0 | - | - | Restricted Stock Units | |
| MGIC Investment Corp | Timothy J. Mattke | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.27 per share. | 28 Feb 2025 | 243,239 | 1,240,197 (0%) | 0% | 24.3 | 5,903,411 | Common Stock |
| Semileds Corp | Trung Tri Doan | Director, Chairman and CEO, Ten Percent Owner | Other type of transaction at price $ 1.66 per share. | 28 Feb 2025 | 240,963 | 1,516,962 (42%) | 6% | 1.7 | 399,999 | Common Stock |
| Upstart Holdings Inc | Dave Girouard | Director, Chief Executive Officer, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 239,628 | 239,628 | - | - | Employee Stock Option (Right to buy) | |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 238,043 | 238,043 | - | - | Stock Option (Right to Buy) | |
| NiSource | Lloyd M. Yates | Director, Director and President & CEO | Grant, award, or other acquisition of securities at price $ 40.81 per share. | 28 Feb 2025 | 233,689 | 476,608 (0%) | 0% | 40.8 | 9,536,848 | Common Stock |
| ARKO Corp (Class A) | Arie Kotler | Director, Chairman, President and CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 229,293 | 12,001,277 | - | 0 | Common Stock, par value $0.0001 per share | |
| Smart Sand Inc | William John Young | Director, CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 228,261 | 1,359,989 (3%) | 0% | 0 | Common Stock | |
| Intel | Michelle Johnston Holthaus | Interim Co-CEO, CEO Intel Prod | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 224,565 | 224,565 | - | - | Restricted Stock Units | |
| Lincoln Educational Services Corp | John A. Bartholdson | Director, Chairman | Sale of securities on an exchange or to another person at price $ 18.09 per share. | 28 Feb 2025 | 224,038 | 201,506 (0%) | 0% | 18.1 | 4,053,273 | Common Stock, no par value per share |
| Invesco Ltd | Andrew R. Schlossberg | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 219,660 | 219,660 | - | - | Restricted Stock Units | |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 218,333 | 0 (0%) | 0% | 0 | Class A Common Stock | |
| American Axle & Manufacturing Holdings Inc | David C. Dauch | Director, Chairman & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 215,393 | 1,181,621 (1%) | 0% | 0 | Common Stock | |
| Intel | David A. Zinsner | Interim Co-CEO, EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 211,091 | 211,091 | - | - | Restricted Stock Units | |
| Intel | David A. Zinsner | Interim Co-CEO, EVP, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 211,091 | 211,091 | - | - | Performance Stock Units | |
| Intel | Christoph Schell | EVP; Chief Cml Ofcr; SMG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 211,091 | 211,091 | - | - | Restricted Stock Units | |
| Intel | Christoph Schell | EVP; Chief Cml Ofcr; SMG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 211,091 | 211,091 | - | - | Performance Stock Units | |
| CVR Energy Inc | Carl C. Icahn | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 17.79 per share. | 28 Feb 2025 | 206,571 | 67,780,774 (67%) | 0% | 17.8 | 3,674,898 | Common Stock, $0.01 par value per share |
| Olema Pharma Inc | David C. Myles | CH. DISCOV. & NON-CLIN DEV OFF | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Olema Pharma Inc | Naseem Zojwalla | CHIEF MEDICAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 205,000 | 205,000 | - | - | Stock Option (Right to Buy) | |
| Applovin Corp (Class A) | Herald Y. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.05 per share. | 28 Feb 2025 | 200,000 | 821,209 | - | 5.1 | 1,010,000 | Class A Common Stock |
| Applovin Corp (Class A) | Herald Y. Chen | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 200,000 | 1,680,201 | - | - | Stock Option (Right to Buy) | |
| Applovin Corp (Class A) | Herald Y. Chen | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 200,000 | 200,000 | - | 0 | Class A Common Stock | |
| Applovin Corp (Class A) | Herald Y. Chen | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 200,000 | 421,209 | - | 0 | Class A Common Stock | |
| Beam Global | Desmond Wheatley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 187,031 | 187,031 | - | - | Restricted Stock Units | |
| Beam Global | Desmond Wheatley | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 187,031 | 313,768 (6%) | 3% | 0 | Common Stock | |
| SPX Tech Inc | Eugene Joseph Lowe | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 12.85 per share. | 28 Feb 2025 | 186,919 | 843,241 (1%) | 0% | 12.8 | 2,401,909 | Common Stock |
| SPX Tech Inc | Eugene Joseph Lowe | Director, PRESIDENT AND CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 186,919 | 0 | - | - | Employee stock option to purchase common stock | |
| Warner Bros. (Class A) | Bruce L. Campbell | Chief Rev & Strategy Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 185,428 | 1,174,875 (0%) | 0% | 0 | Series A Common Stock | |
| Warner Bros. (Class A) | Jean-Briac Perrette | Pres.&CEO, Global Streaming | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 185,428 | 1,542,680 (0%) | 0% | 0 | Series A Common Stock | |
| SEACOR Marine Holdings Inc | John Gellert | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 183,084 | 1,057,780 (4%) | 0% | 0 | Common Stock | |
| Alight Inc (Class A) | Allison Bassiouni | Chief Delivery Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 179,376 | 255,409 | - | 0 | Class A Common Stock | |
| Alight Inc (Class A) | Deepika Duggirala | Chief Technology Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 179,376 | 247,360 | - | 0 | Class A Common Stock | |
| Alight Inc (Class A) | Robert Sturrus W. | Chief Client Officer | 28 Feb 2025 | 179,376 | 250,229 | - | 0 | Class A Common Stock | ||
| Gaming and Leisure Properties Inc | Peter M. Carlino | Director, Chairman and CEO | Other type of transaction at price $ 0.00 per share. | 28 Feb 2025 | 177,875 | 4,707,917 (2%) | 0% | 0 | Common Stock | |
| Lam Research | Timothy M. Archer | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 177,750 | 177,750 | - | - | Market-based Performance Restricted Stock Unit | |
| Goosehead Insurance Inc (Class A) | Thomas McConnon | Director | Sale of securities on an exchange or to another person at price $ 121.05 per share. | 28 Feb 2025 | 177,000 | 339,008 (2%) | 1% | 121.1 | 21,425,850 | Class A Common Stock |
| SkyAI Inc | Robert M. Hayes | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.04 per share. | 28 Feb 2025 | 175,000 | 275,882 | - | 0.0 | 7,000 | Common Stock |
| Warner Bros. (Class A) | Gunnar Wiedenfels | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 174,521 | 1,432,407 (0%) | 0% | 0 | Series A Common Stock | |
| American Axle & Manufacturing Holdings Inc | David C. Dauch | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.96 per share. | 28 Feb 2025 | 173,867 | 966,228 (0%) | 0% | 5.0 | 862,380 | Common Stock |
| Gray Television Inc (Class A) | Hilton H. Howell | Director, Chairman, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 28 Feb 2025 | 172,872 | 3,726,030 (52%) | 2% | 6.6 | 1,132,312 | Class A Common Stock |
| Gray Television Inc (Class A) | Robin R. Howell | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 6.55 per share. | 28 Feb 2025 | 172,872 | 3,726,030 (52%) | 2% | 6.6 | 1,132,312 | Class A Common Stock |
| Teladoc Health Inc | Mala Murthy | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 172,594 | 172,594 | - | - | Restricted Stock Units | |
| Fidelity National Information | Stephanie L. Ferris | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 168,953 | 168,953 | - | - | Restricted Stock Units | |
| NuScale Power Corp (Class A) | John L. Hopkins | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 168,702 | 168,702 | - | - | Restricted Stock Unit | |
| Taboola.com Ltd | Zvi Limon | Director | Purchase of securities on an exchange or from another person at price $ 2.79 per share. | 28 Feb 2025 | 168,506 | 3,155,889 | - | 2.8 | 470,132 | Ordinary Shares |
| Grocery Outlet Holding Corp | Jason Potter | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 168,492 | 168,492 (0%) | 0% | 0 | Common Stock | |
| Coupang Inc (Class A) | Harold Rogers | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 168,361 | 788,301 | - | 0 | Class A Common Stock | |
| CVR Energy Inc | Carl C. Icahn | Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 18.01 per share. | 28 Feb 2025 | 167,079 | 67,947,853 (67%) | 0% | 18.0 | 3,009,093 | Common Stock, $0.01 par value per share |
| NextTrip Inc | William Kerby | Chief Executive Officer | 28 Feb 2025 | 165,562 | 331,124 | - | - | Series L Nonvoting Convertible Preferred Stock | ||
| NextTrip Inc | William Kerby | Chief Executive Officer | 28 Feb 2025 | 165,562 | 331,124 | - | - | Series L Nonvoting Convertible Preferred Stock | ||
| Sinclair Inc (Class A) | Jason Ryan Smith | Executive Vice Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 159,607 | 197,173 (0%) | 0% | - | Class A Common Stock | |
| RXO Inc | Drew M. Wilkerson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 158,769 | 680,406 | - | - | Restricted Stock Unit | |
| Restaurant Brands Intl Inc | Joshua Kobza | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 153,397 | 153,397 | - | - | Performance Share Units | |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 28 Feb 2025 | 152,990 | 324,510 | - | 6.3 | 960,777 | Class A Common Stock |
| UWM Holdings Corp (Class A) | Mathew Ishbia | Director, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 152,990 | 0 | - | - | Restricted Stock Units | |
| Arcutis Biotherapeutics Inc | Todd Franklin Watanabe | Director, See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 151,000 | 955,129 (2%) | 0% | 0 | Common Stock | |
| Sunrun Inc | Edward Fenster | Director | Purchase of securities on an exchange or from another person at price $ 6.80 per share. | 28 Feb 2025 | 150,000 | 1,358,182 (1%) | 0% | 6.8 | 1,020,600 | Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.02 per share. | 28 Feb 2025 | 149,756 | 762,114 (0%) | 0% | 55.0 | 8,239,575 | Common Stock |
| Moderna | Stephen Hoge | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 148,524 | 148,524 | - | - | Restricted Stock Units | |
| Aurinia Pharma Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.00 per share. | 28 Feb 2025 | 148,038 | 9,429,500 (11%) | 0% | 8 | 1,184,304 | Common Shares |
| CVRx Inc | Kevin Hykes | Director, PRES & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 148,000 | 148,000 | - | - | Stock Option (right to buy) | |
| Sinclair Inc (Class A) | Robert D. Weisbord | COO & President of Broadcast | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 147,801 | 284,973 (0%) | 0% | - | Class A Common Stock | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 147,678 | 147,678 | - | - | Performance-Based Restricted Stock Units | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 147,678 | 652,807 | - | - | Time-Based Restricted Stock Units | |
| SEACOR Marine Holdings Inc | Jesus Llorca | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 147,489 | 578,127 (2%) | 0% | 0 | Common Stock | |
| Sinclair Inc (Class A) | Lucy A. Rutishauser | SVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 144,196 | 239,716 (0%) | 0% | - | Class A Common Stock | |
| American Axle & Manufacturing Holdings Inc | Michael Joseph Lynch | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 142,106 | 531,010 (0%) | 0% | 0 | Common Stock | |
| American Axle & Manufacturing Holdings Inc | Christopher J. May | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 142,106 | 727,089 (0%) | 0% | 0 | Common Stock | |
| Aligos Therapeutics Inc | Lawrence M. Blatt | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,103 | 140,103 | - | - | Stock Option (Right to Buy) | |
| Corcept Therapeutics Inc | G. Charles Robb | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Atabak Mokari | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Sean Maduck | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Joseph Douglas Lyon | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Corcept Therapeutics Inc | Hazel Hunt | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock Option (right to buy) | |
| Corcept Therapeutics Inc | William Guyer | Chief Development Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 140,000 | 140,000 | - | - | Stock option (right to buy) | |
| Sinclair Inc (Class A) | David D. Smith | Director, Executive Chairman, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 28 Feb 2025 | 139,294 | 598,698 (0%) | 0% | 13.9 | 1,932,008 | Class A Common Stock |
| Hayward Holdings Inc | Kevin P. Holleran | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 138,027 | 660,826 | - | 0 | Common Stock | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 135,567 | 805,358 (0%) | 0% | 0 | Common Stock | ||
| ARKO Corp (Class A) | Arie Kotler | Director, Chairman, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 133,185 | 12,078,629 | - | - | Common Stock, par value $0.0001 per share | |
| Coupang Inc (Class A) | Hanseung Kang | Rep Director, Business Mngmt | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 131,258 | 709,772 | - | 0 | Class A Common Stock | |
| Warner Bros. (Class A) | Gerhard Zeiler | President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 130,891 | 1,035,601 (0%) | 0% | 0 | Series A Common Stock | |
| Aptiv | Kevin P. Clark | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 130,591 | 492,170 (0%) | 0% | 0 | Ordinary Shares | |
| Smart Sand Inc | Lee E. Beckelman | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 130,435 | 745,048 (1%) | 0% | 0 | Common Stock | |
| Smart Sand Inc | Charles E. Young | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 130,435 | 601,109 (1%) | 0% | 0 | Common Stock | |
| GoDaddy | Amanpal S. Bhutani | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 129,318 | 508,649 (0%) | 0% | 0 | Class A Common Stock | |
| Kimberly-Clark | Michael D. Hsu | Director, Chairman of the Board and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 128,524 | 303,883 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 128,438 | 128,438 | - | - | Employee Stock Option (right to buy) | |
| Brandywine Realty Trust | Thomas E. Wirth | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 127,341 | 701,180 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 126,416 | 126,416 | - | - | Employee Stock Option (right to buy) | ||
| Gray Television Inc (Class A) | Kevin P. Latek | EVP Chief L & D Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.76 per share. | 28 Feb 2025 | 125,803 | 638,006 (0%) | 0% | 3.8 | 473,019 | Common Stock |
| MGIC Investment Corp | Salvatore A. Miosi | President & COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.27 per share. | 28 Feb 2025 | 125,377 | 339,401 (0%) | 0% | 24.3 | 3,042,900 | Common Stock |
| Resolute Holdings Management Inc | John D. Cote | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 125,000 | 125,000 | - | - | Common Stock, par value $0.0001 per share | |
| SkyAI Inc | Robert M. Hayes | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 0.03 per share. | 28 Feb 2025 | 125,000 | 400,882 | - | 0.0 | 3,750 | Common Stock |
| Aurinia Pharma Inc | Joseph M. Miller | Chief Financial Officer | 28 Feb 2025 | 124,393 | 124,393 | - | - | Employee Stock Option (right to buy) | ||
| Taboola.com Ltd | Adam Singolda | Director, Founder and CEO | Purchase of securities on an exchange or from another person at price $ 2.70 per share. | 28 Feb 2025 | 123,771 | 14,586,714 | - | 2.7 | 334,182 | Ordinary Shares |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 122,500 | 0 | - | - | Performance Stock Units | |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 122,500 | 1,753,560 (0%) | 0% | 0 | Common Stock | |
| Lam Research | Timothy M. Archer | President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 118,500 | 1,051,440 (0%) | 0% | 0 | Common Stock | |
| Intel | April Miller Boise | EVP and Chief Legal Officer | 28 Feb 2025 | 117,897 | 117,897 | - | - | Restricted Stock Units | ||
| Intel | April Miller Boise | EVP and Chief Legal Officer | 28 Feb 2025 | 117,897 | 117,897 | - | - | Performance Stock Units | ||
| Tetra Technologies Inc | Elijio V. Serrano | Sr. Vice President & CFO | 28 Feb 2025 | 116,564 | 116,564 | - | - | Restricted Stock Units | ||
| SoundThinking Inc | Ralph A. Clark | Director, PRESIDENT AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 116,195 | 632,902 (5%) | 1% | 0 | Common Stock | |
| Beam Global | Desmond Wheatley | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Feb 2025 | 114,744 | 199,025 (3%) | 2% | 0 | Common Stock | |
| Aurinia Pharma Inc | Joseph M. Miller | Chief Financial Officer | 28 Feb 2025 | 114,711 | 695,374 (0%) | 0% | 0 | Common Stock | ||
| Marathon Digital Holdings Inc | Zabi Nowaid | General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 109,881 | 875,782 (11%) | 1% | 0 | Common Stock | |
| Teladoc Health Inc | Adam C. Vandervoort | CHIEF LEGAL OFFICER, SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 109,832 | 109,832 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Kelly Bliss | President, U.S. Group Health | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 109,832 | 109,832 | - | - | Restricted Stock Units | |
| Gray Television Inc (Class A) | D Patrick LaPlatney | Director, President and Co-CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.76 per share. | 28 Feb 2025 | 109,318 | 1,233,063 (1%) | 0% | 3.8 | 411,036 | Common Stock |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 109,167 | 109,167 (0%) | 0% | 0 | Class A Common Stock | |
| Vertiv Holdings Co (Class A) | Roger B. Fradin | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 109,166 | 109,166 (0%) | 0% | 0 | Class A Common Stock | |
| Ultragenyx Pharmaceutical Inc | Emil D. Kakkis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 107,292 | 715,165 (1%) | 0% | 0 | Common Stock | |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 106,672 | 173,129 (0%) | 0% | 0 | Class A Common Stock | |
| Roku Inc (Class A) | Anthony Wood | Director, CEO and Chairman BOD, Ten Percent Owner | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 106,672 | 133,210 (0%) | 0% | 0 | Class A Common Stock | |
| Invesco Ltd | L. Allison Dukes | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 105,451 | 105,451 | - | - | Restricted Stock Units | |
| National Storage Affiliates Trust | David G. Cramer | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 105,171 | 1,912,204 (3%) | 0% | 0 | Common shares of beneficial interest, $0.01 par value | |
| National Storage Affiliates Trust | David G. Cramer | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 105,171 | 1,912,204 (3%) | 0% | 0 | Common shares of beneficial interest, $0.01 par value | |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.18 per share. | 28 Feb 2025 | 104,986 | 1,631,060 (0%) | 0% | 11.2 | 1,173,743 | Common Stock |
| Teladoc Health Inc | Carlos Nueno | President, International | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 104,602 | 104,602 | - | - | Restricted Stock Units | |
| Teladoc Health Inc | Fernando M. Rodrigues | President of BetterHelp | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 104,602 | 104,602 | - | - | Restricted Stock Units | |
| Safehold Inc | Jay Sugarman | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 104,502 | 1,828,548 (3%) | 0% | 0 | Common Stock | |
| NuScale Power Corp (Class A) | John L. Hopkins | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 104,166 | 208,334 | - | - | Restricted Stock Unit | |
| NuScale Power Corp (Class A) | John L. Hopkins | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 104,166 | 178,126 | - | 0 | Class A Common Stock | |
| Public Service Enterprise | Ralph A. Larossa | Director, Chair, President and CEO | Grant, award, or other acquisition of securities at price $ 81.04 per share. | 28 Feb 2025 | 102,689 | 255,091 (0%) | 0% | 81.0 | 8,321,979 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 102,406 | 631,755 (0%) | 0% | 0 | Common Stock | |
| Grocery Outlet Holding Corp | Steven K. Wilson | EVP, Chief Purchasing Officer | 28 Feb 2025 | 102,364 | 102,364 | - | - | Stock Options (Right to Buy) | ||
| Drilling Tools Intl Corp | Aldo Rodriguez | Vice President of Sales | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 102,000 | 102,000 | - | - | Restricted Stock Units | |
| Synchrony Financial | Brian D. Doubles | Director, See remarks | Grant, award, or other acquisition of securities at price $ 60.68 per share. | 28 Feb 2025 | 101,970 | 779,391 (0%) | 0% | 60.7 | 6,187,540 | Common Stock |
| Brandywine Realty Trust | H. Jeffrey Devuono | EVP & Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 100,967 | 589,998 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Somnigroup Intl Inc | Scott L. Thompson | Director, CEO & PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 100,748 | 100,748 | - | - | Performance Restricted Stock Units | |
| Aurinia Pharma Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 7.97 per share. | 28 Feb 2025 | 100,720 | 8,929,500 (10%) | 0% | 8.0 | 802,738 | Common Shares |
| Occidental Petroleum | Vicki A. Hollub | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 100,328 | 1,011,812 (0%) | 0% | 0 | Common Stock | |
| Greenwave Tech Soln Inc | Jason T. Adelman | Director | 28 Feb 2025 | 100,000 | 300,000 | - | 0.3 | 25,000 | Common Stock | |
| Aurinia Pharma Inc | Kevin C. Tang | Director | Purchase of securities on an exchange or from another person at price $ 8.09 per share. | 28 Feb 2025 | 100,000 | 10,029,500 (11%) | 0% | 8.1 | 809,000 | Common Shares |
| American Axle & Manufacturing Holdings Inc | Terri M. Kemp | SVP - HR & Sustainability | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99,474 | 380,507 (0%) | 0% | 0 | Common Stock | |
| Arcutis Biotherapeutics Inc | Patrick Burnett E. | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99,000 | 99,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Larry Todd Edwards | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 99,000 | 99,000 | - | - | Stock Option (right to buy) | |
| Artivion Inc | James Patrick Mackin | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 98,524 | 762,406 (1%) | 0% | 0 | Common Stock | |
| CVRx Inc | Kevin Hykes | Director, PRES & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 98,000 | 128,000 | - | 0 | Common Stock | |
| Bausch Health Companies Inc | Thomas J. Appio | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 28 Feb 2025 | 96,911 | 1,783,249 (0%) | 0% | 7.4 | 721,018 | Common Shares, No Par Value |
| American Axle & Manufacturing Holdings Inc | David C. Dauch | Director, Chairman & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.96 per share. | 28 Feb 2025 | 96,497 | 1,085,124 (0%) | 0% | 5.0 | 478,625 | Common Stock |
| NiSource | Lloyd M. Yates | Director, Director and President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 40.81 per share. | 28 Feb 2025 | 96,164 | 380,444 (0%) | 0% | 40.8 | 3,924,453 | Common Stock |
| Aurinia Pharma Inc | Greg Keenan | Chief Medical Officer | 28 Feb 2025 | 95,570 | 95,570 | - | - | Employee Stock Option (right to buy) | ||
| fuboTV Inc | Alberto Horihuela Suarez | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 94,912 | 94,912 | - | - | Restricted Stock Units | |
| Rackspace Tech Inc | Mark A. Marino | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 2.34 per share. | 28 Feb 2025 | 94,571 | 1,995,033 | - | 2.3 | 221,296 | Common Stock |
| Intel | Scott Gawel | CVP, Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 94,318 | 94,318 | - | - | Restricted Stock Units | |
| Brandywine Realty Trust | George D. Johnstone | EVP, Operations | 28 Feb 2025 | 94,262 | 542,891 (0%) | 0% | 0 | Common Shares of Beneficial Interest | ||
| Brandywine Realty Trust | William D. Redd | EVP & Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 94,262 | 455,079 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Molson Coors Beverage (Class B) | Gavin D.K. Hattersley | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 93,907 | 276,746 (0%) | 0% | 0 | Class B Common Stock | |
| Fidelity National Information | Stephanie L. Ferris | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 93,502 | 93,502 | - | - | Restricted Stock Units | |
| AbbVie | Richard A. Gonzalez | Director | Sale of securities on an exchange or to another person at price $ 205.11 per share. | 28 Feb 2025 | 92,460 | 395,097 (0%) | 0% | 205.1 | 18,964,471 | Common Stock, $0.01 par value |
| Synchrony Financial | Brian D. Doubles | Director, See remarks | Sale of securities on an exchange or to another person at price $ 60.05 per share. | 28 Feb 2025 | 91,154 | 677,421 (0%) | 0% | 60.1 | 5,473,798 | Common Stock |
| Invesco Ltd | Douglas J. Sharp | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 90,569 | 90,569 | - | - | Restricted Stock Units | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 90,036 | 90,036 | - | - | Restricted Stock Unit | |
| Grocery Outlet Holding Corp | Pamela B. Burke | EVP, Chief Stores Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 89,714 | 89,714 | - | - | Stock Options (Right to Buy) | |
| Global Payments | Cameron M. Bready | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 89,366 | 89,366 | - | - | Stock Option (Right to Buy) | |
| Arcutis Biotherapeutics Inc | David J. Topper | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 89,000 | 89,000 | - | - | Stock Option (right to buy) | |
| Arcutis Biotherapeutics Inc | Masaru Matsuda | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 89,000 | 89,000 | - | - | Stock Option (right to buy) | |
| Warner Bros. (Class A) | Jean-Briac Perrette | Pres.&CEO, Global Streaming | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.46 per share. | 28 Feb 2025 | 88,929 | 1,357,252 (0%) | 0% | 11.5 | 1,019,126 | Series A Common Stock |
| Flywire Corp | Michael Massaro | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.59 per share. | 28 Feb 2025 | 88,731 | 1,146,987 | - | 0.6 | 52,351 | Voting Common Stock |
| Flywire Corp | Michael Massaro | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 88,731 | 0 | - | - | Employee Stock Option (right to buy) | |
| Allison Transmission Holdings Inc | David S. Graziosi | Director, Chair, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 88,600 | 281,234 (0%) | 0% | - | Common Stock | |
| Allison Transmission Holdings Inc | David S. Graziosi | Director, Chair, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 88,600 | 0 | - | - | Performance Stock Units | |
| Grocery Outlet Holding Corp | Ramesh Chikkala | EVP, Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 88,340 | 88,340 | - | - | Stock Options (Right to Buy) | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 87,943 | 87,943 | - | - | Restricted Stock Units | |
| Healthcare Realty Trust Inc (Class A) | Robert E. Hull | EVP and COO | Grant, award, or other acquisition of securities at price $ 17.13 per share. | 28 Feb 2025 | 87,565 | 289,187 (0%) | 0% | 17.1 | 1,499,988 | Common Stock |
| Tetra Technologies Inc | Matthew J. Sanderson | Executive Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 87,423 | 87,423 | - | - | Restricted Stock Units | |
| Aptiv | Kevin P. Clark | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 87,062 | 361,579 (0%) | 0% | 0 | Ordinary Shares | |
| Smart Sand Inc | Robert Kiszka | Executive VP of Operations | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 86,957 | 529,388 (1%) | 0% | 0 | Common Stock | |
| Smart Sand Inc | Ronald P. Whelan | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 86,957 | 448,485 (1%) | 0% | 0 | Common Stock | |
| Smart Sand Inc | James Douglas Young | SEE REMARKS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 86,957 | 360,613 (0%) | 0% | 0 | Common Stock | |
| National Storage Affiliates Trust | David G. Cramer | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 85,717 | 525,614 | - | - | Class A OP Units | |
| Aveanna Healthcare Holdings Inc | Ed Reisz | Chief Administration Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 85,598 | 1,281,615 | - | 0 | Common Stock, par value $0.01 per share | |
| Aveanna Healthcare Holdings Inc | Jerry Perchik | Chief Legal Officer, Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 85,598 | 248,980 | - | 0 | Common Stock, par value $0.01 per share | |
| Bausch Health Companies Inc | Thomas J. Appio | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 7.44 per share. | 28 Feb 2025 | 85,100 | 1,880,160 (0%) | 0% | 7.4 | 633,144 | Common Shares, No Par Value |
| Fortive | Tamara S. Newcombe | President & CEO of PT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 84,900 | 84,900 | - | - | Employee Stock Option (Right to Buy) | |
| Blue Bird Corp | Philip Horlock | Director | 28 Feb 2025 | 84,413 | 266,667 (0%) | 0% | 35.1 | 2,966,273 | Common Stock, par value $0.0001 per share | |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 84,106 | 529,349 (0%) | 0% | 0 | Common Stock | |
| Invesco Ltd | Stephanie C. Butcher | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 83,604 | 83,604 | - | - | Restricted Stock Units | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 82,781 | 669,791 (0%) | 0% | 0 | Common Stock | ||
| Tetra Technologies Inc | Roy E. McNiven | Sr. Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 81,595 | 81,595 | - | - | Restricted Stock Units | |
| Tetra Technologies Inc | Timothy C. Moeller | SVP - Supply Chain & Chemicals | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 81,595 | 81,595 | - | - | Restricted Stock Units | |
| Absci Corp | Zachariah Jonasson | CFO / CBO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 81,500 | 423,254 | - | 0 | Common Stock | |
| Aurinia Pharma Inc | Joseph M. Miller | Chief Financial Officer | 28 Feb 2025 | 81,457 | 580,663 (0%) | 0% | 0 | Common Stock | ||
| Grocery Outlet Holding Corp | Andrea R. Bortner | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 81,094 | 81,094 | - | - | Stock Options (Right to Buy) | |
| ProPetro Holding Corp | Samuel D. Sledge | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 80,943 | 220,008 | - | - | Restricted Stock Units | |
| ProPetro Holding Corp | Samuel D. Sledge | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 80,943 | 389,591 (0%) | 0% | - | Common Stock | |
| CF Industries | W. Anthony Will | Director, President & CEO | 28 Feb 2025 | 80,773 | 636,307 (0%) | 0% | 0 | Common stock, par value $0.01 per share | ||
| Broadstone Net Lease Inc | John D. Moragne | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 80,744 | 433,752 | - | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | John Gellert | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 80,285 | 80,285 | - | - | Performance Restricted Stock Units | |
| Life Time Grp Holdings Inc | Parham Javaheri | EVP &PRESIDENT CLUB OPERATIONS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 79,970 | 356,789 | - | 0 | Common Stock | |
| Grocery Outlet Holding Corp | Eric J. Lindberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 79,628 | 199,502 (0%) | 0% | 0 | Common Stock | |
| Aptiv | Joseph R. Massaro | Vice Chairman, ECG | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 79,556 | 364,392 (0%) | 0% | 0 | Ordinary Shares | |
| Warner Bros. (Class A) | Gunnar Wiedenfels | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.46 per share. | 28 Feb 2025 | 78,928 | 1,257,886 (0%) | 0% | 11.5 | 904,515 | Series A Common Stock |
| Aveanna Healthcare Holdings Inc | Matthew Buckhalter | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 78,533 | 412,878 | - | 0 | Common Stock, par value $0.01 per share | |
| Ultragenyx Pharmaceutical Inc | Emil D. Kakkis | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 78,448 | 78,448 | - | - | Stock Option (Right to Buy) | |
| Alight Inc (Class A) | Jeremy J. Heaton | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 78,160 | 673,233 | - | 0 | Class A Common Stock | |
| Life Time Grp Holdings Inc | Eric J. Buss | EVP & CHIEF ADMIN. OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 76,514 | 396,049 | - | 0 | Common Stock | |
| Grocery Outlet Holding Corp | Luke D. Thompson | EVP, GC and Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 76,410 | 76,410 | - | - | Stock Options (Right to Buy) | |
| SEACOR Marine Holdings Inc | Andrew H. Everett | Sr. VP, General Counsel & Secy | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 76,290 | 309,792 (1%) | 0% | 0 | Common Stock | |
| NuScale Power Corp (Class A) | Robert Ramsey Hamady | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 75,625 | 75,625 | - | - | Restricted Stock Unit | |
| Theravance Biopharma Inc | Rhonda Farnum | SVP, COMM & MEDICAL AFFAIRS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 75,000 | 374,038 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Aziz Sawaf | SVP & CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 75,000 | 374,138 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Brett A. Grimaud | SVP, GEN COUNSEL AND SECRETARY | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 75,000 | 393,811 (0%) | 0% | 0 | Ordinary Shares | |
| Theravance Biopharma Inc | Aine Miller | SVP, DEV & HEAD OF IRE OFFICE | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 75,000 | 214,261 (0%) | 0% | 0 | Ordinary Shares | |
| RXO Inc | Drew M. Wilkerson | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 74,932 | 74,932 | - | - | Restricted Stock Unit | |
| Lexicon Pharma Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 74,227 | 148,453 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 74,227 | 185,560 (0%) | 0% | - | Common Stock | |
| Western Digital | Wissam G. Jabre | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 74,039 | 335,672 (0%) | 0% | 0 | Common Stock | |
| Janus Henderson Grp PLC | Ali Dibadj | Director, CEO | Grant, award, or other acquisition of securities at price $ 41.71 per share. | 28 Feb 2025 | 73,508 | 353,908 (0%) | 0% | 41.7 | 3,066,019 | Common Stock |
| Ultragenyx Pharmaceutical Inc | Emil D. Kakkis | Director, President & CEO | Sale of securities on an exchange or to another person at price $ 42.10 per share. | 28 Feb 2025 | 73,434 | 641,731 (1%) | 0% | 42.1 | 3,091,571 | Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 55.02 per share. | 28 Feb 2025 | 73,397 | 641,065 (0%) | 0% | 55.0 | 4,038,303 | Common Stock |
| Resolute Holdings Management Inc | John D. Cote | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 73,330 | 73,330 | - | - | Common Stock, par value $0.0001 per share | |
| AbbVie | Richard A. Gonzalez | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 205.02 per share. | 28 Feb 2025 | 73,209 | 487,557 (0%) | 0% | 205.0 | 15,009,309 | Common Stock, $0.01 par value |
| Invesco Ltd | Andrew Tak Shing Lo | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 72,455 | 72,455 | - | - | Restricted Stock Units | |
| L3Harris Tech | Christopher E. Kubasik | Director, Chair and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 72,028 | 72,028 | - | - | Non-Qualified Stock Option (Right to Buy) | |
| U.S. Bancorp | Andrew Cecere | Director, Chairman and CEO | 28 Feb 2025 | 71,959 | 1,360,414 (0%) | 0% | 46.9 | 3,374,877 | Common Stock, $0.01 par value | |
| Brighthouse Fin Inc | Eric T. Steigerwalt | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 71,659 | 342,731 (0%) | 0% | 0 | Common Stock | |
| SEACOR Marine Holdings Inc | Gregory S. Rossmiller | SVP & CAO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 71,205 | 296,102 (1%) | 0% | 0 | Common Stock | |
| Curbline Properties Corp | David R. Lukes | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.42 per share. | 28 Feb 2025 | 70,771 | 1,045,362 | - | 24.4 | 1,728,228 | Common Stock |
| NuScale Power Corp (Class A) | Clayton Scott | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 69,808 | 69,808 | - | - | Restricted Stock Unit | |
| Sinclair Inc (Class A) | Lucy A. Rutishauser | SVP & CFO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 28 Feb 2025 | 69,648 | 170,068 (0%) | 0% | 13.9 | 966,018 | Class A Common Stock |
| ARKO Corp (Class A) | Arie Kotler | Director, Chairman, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 69,581 | 139,161 | - | - | Restricted Stock Units | |
| CNH Industrial NV | Oddone Incisa della Rocchetta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 69,404 | 854,065 (9%) | 0% | 0 | Common Shares | |
| Lexicon Pharma Inc | Brian T. Crum | SVP, General Counsel & Secr. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 69,387 | 306,437 (0%) | 0% | - | Common Stock | |
| Lexicon Pharma Inc | Brian T. Crum | SVP, General Counsel & Secr. | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 69,387 | 138,773 | - | - | Restricted Stock Units | |
| Visteon Corp | Sachin S. Lawande | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 69,188 | 69,188 | - | - | Performance Rights | |
| Restaurant Brands Intl Inc | Sami A. Siddiqui | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 69,028 | 69,028 | - | - | Performance Share Units | |
| Sinclair Inc (Class A) | David B. Gibber | EVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 68,493 | 213,853 (0%) | 0% | - | Class A Common Stock | |
| Warner Bros. (Class A) | Bruce L. Campbell | Chief Rev & Strategy Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.46 per share. | 28 Feb 2025 | 68,269 | 989,447 (0%) | 0% | 11.5 | 782,363 | Series A Common Stock |
| Lexicon Pharma Inc | Alan J. Main | EVP, Innov & Chem Sciences | 28 Feb 2025 | 68,243 | 136,487 | - | - | Restricted Stock Units | ||
| Lexicon Pharma Inc | Alan J. Main | EVP, Innov & Chem Sciences | 28 Feb 2025 | 68,243 | 382,538 (0%) | 0% | - | Common Stock | ||
| Opko Health Inc | Phillip Frost | Director, CEO & Chairman, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 1.71 per share. | 28 Feb 2025 | 67,434 | 213,301,448 (31%) | 0% | 1.7 | 115,312 | Common Stock |
| MGIC Investment Corp | Nathaniel H. Colson | Officer EVP, CFO & CRO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.27 per share. | 28 Feb 2025 | 67,072 | 240,929 (0%) | 0% | 24.3 | 1,627,837 | Common Stock |
| Synchrony Financial | Brian D. Doubles | Director, See remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 60.68 per share. | 28 Feb 2025 | 66,780 | 712,611 (0%) | 0% | 60.7 | 4,052,210 | Common Stock |
| NuScale Power Corp (Class A) | John L. Hopkins | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 16.45 per share. | 28 Feb 2025 | 66,502 | 111,624 | - | 16.4 | 1,093,692 | Class A Common Stock |
| Invesco Ltd | Tony Wong L. | Senior Managing Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 66,451 | 66,451 | - | - | Restricted Stock Units | |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 65,902 | 739,456 (0%) | 0% | 8 | 527,216 | Common Stock | |
| Lexicon Pharma Inc | Craig B. Granowitz | SVP, Chief Medical Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.67 per share. | 28 Feb 2025 | 65,308 | 120,252 (0%) | 0% | 0.7 | 43,756 | Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 8.00 per share. | 28 Feb 2025 | 64,872 | 566,883 (0%) | 0% | 8 | 518,976 | Common Stock |
| AdvanSix Inc | Erin N. Kane | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 64,865 | 545,447 (1%) | 0% | 0 | Common Stock, par value $0.01 | |
| OppFi Inc (Class A) | Todd G. Schwartz | Director, Chief Executive Officer, Ten Percent Owner | Sale or transfer of securities back to the company at price $ 0.00 per share. | 28 Feb 2025 | 64,865 | 62,178,190 | - | 0 | Class V Common Stock | |
| SEACOR Marine Holdings Inc | Jesus Llorca | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 64,675 | 64,675 | - | - | Performance Restricted Stock Units | |
| Bank of America | Alastair M. Borthwick | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 64,450 | 0 | - | - | 2022 Performance Restricted Stock Units | |
| Bank of America | Alastair M. Borthwick | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 64,450 | 423,741 (0%) | 0% | - | Common Stock | |
| NVIDIA | Colette M. Kress | EVP & Chief Financial Officer | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 64,080 | 3,059,644 (0%) | 0% | 0 | Common | |
| Equitable Holdings Inc | Nicholas B. Lane | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 63,870 | 171,420 (0%) | 0% | 0 | Common Stock | |
| Evertec Inc | Morgan M. Schuessler | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 37.34 per share. | 28 Feb 2025 | 63,738 | 335,840 (0%) | 0% | 37.3 | 2,379,977 | Common Stock |
| ARKO Corp (Class A) | Arie Kotler | Director, Chairman, President and CEO, Ten Percent Owner | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 63,604 | 0 | - | - | Restricted Stock Units | |
| Moderna | James M Mock | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 63,478 | 63,478 | - | - | Stock Option (Right to Buy) | |
| Fidelity National Information | Stephanie L. Ferris | CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 63,397 | 183,589 (0%) | 0% | 0 | Common Stock | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 63,394 | 1,018,286 (0%) | 0% | 0 | Ordinary Shares | |
| Gates Industrial Corp PLC | Ivo Jurek | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 63,394 | 589,413 | - | - | Time-Based Restricted Stock Units | |
| NiSource | Melody Birmingham | EVP & Grp President, Utilities | Grant, award, or other acquisition of securities at price $ 40.81 per share. | 28 Feb 2025 | 63,228 | 113,619 (0%) | 0% | 40.8 | 2,580,335 | Common Stock |
| Standard BioTools Inc | Troy M. Cox | Director | Grant, award, or other acquisition of securities at price $ 1.06 per share. | 28 Feb 2025 | 62,910 | 224,730 (0%) | 0% | 1.1 | 66,999 | Common Stock |
| Bandwidth Inc (Class A) | Devesh Agarwal | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 62,617 | 62,617 | - | - | Restricted Stock Units | |
| Aurinia Pharma Inc | Greg Keenan | Chief Medical Officer | 28 Feb 2025 | 62,583 | 174,028 (0%) | 0% | 0 | Common Stock | ||
| TransUnion | Christopher A. Cartwright | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 62,209 | 424,677 (0%) | 0% | 0 | Common Stock | |
| Aurinia Pharma Inc | Joseph M. Miller | Chief Financial Officer | 28 Feb 2025 | 61,859 | 633,515 (0%) | 0% | 8 | 494,872 | Common Stock | |
| Life Time Grp Holdings Inc | Ritadhwaja Jebens Singh | EVP & CHIEF DIGITAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 61,705 | 197,925 | - | 0 | Common Stock | |
| Restaurant Brands Intl Inc | Axel MR Schwan | Pres., Tim Hortons Americas | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 61,359 | 61,359 | - | - | Performance Share Units | |
| Restaurant Brands Intl Inc | Thomas B. Curtis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 61,359 | 61,359 | - | - | Performance Share Units | |
| Fortive | James A. Lico | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 61,320 | 61,320 | - | - | Employee Stock Option (Right to Buy) | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 61,103 | 123,775 (0%) | 0% | 0 | Common Stock | |
| AT&T | David R. McAtee | Sr. Exec. VP and Gen. Counsel | Gift of securities by or to the insider at price $ 0.00 per share. | 28 Feb 2025 | 61,103 | 239,857 (0%) | 0% | 0 | Common Stock | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 93.81 per share. | 28 Feb 2025 | 60,420 | 696,790 (0%) | 0% | 93.8 | 5,668,000 | Common Stock |
| Taboola.com Ltd | Adam Singolda | Director, Founder and CEO | Purchase of securities on an exchange or from another person at price $ 2.72 per share. | 28 Feb 2025 | 60,229 | 14,462,943 | - | 2.7 | 163,823 | Ordinary Shares |
| PaySign Inc | Jeffery Bradford Baker | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 60,000 | 247,065 (0%) | 0% | 0 | Common Stock | |
| PaySign Inc | Jeffery Bradford Baker | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 60,000 | 60,000 | - | - | Stock Grant | |
| Drilling Tools Intl Corp | Trent Pope | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 60,000 | 60,000 | - | - | Restricted Stock Units | |
| Range Resources Corp | Mark S. Scucchi | EVP & CFO | Grant, award, or other acquisition of securities at price $ 37.12 per share. | 28 Feb 2025 | 59,994 | 750,088 (0%) | 0% | 37.1 | 2,226,977 | Common Stock |
| Range Resources Corp | Dennis L. Degner | Chief Executive Officer & Pres | Grant, award, or other acquisition of securities at price $ 37.12 per share. | 28 Feb 2025 | 59,994 | 684,244 (0%) | 0% | 37.1 | 2,226,977 | Common Stock |
| MGIC Investment Corp | Paula C. Maggio | EVP and General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 24.27 per share. | 28 Feb 2025 | 59,207 | 200,920 (0%) | 0% | 24.3 | 1,436,954 | Common Stock |
| Aurinia Pharma Inc | Matthew Donley | Chief Operating Officer | 28 Feb 2025 | 58,991 | 680,465 (0%) | 0% | 7.9 | 467,209 | Common Stock | |
| Tetra Technologies Inc | Alicia P. Boston Shoemake | Sr. VP and General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 58,282 | 58,282 | - | - | Restricted Stock Units | |
| NuScale Power Corp (Class A) | Carl Fisher | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 58,173 | 58,173 | - | - | Restricted Stock Unit | |
| Sinclair Inc (Class A) | Robert D. Weisbord | COO & President of Broadcast | Payment of exercise price or tax liability using portion of securities received from the company at price $ 13.87 per share. | 28 Feb 2025 | 58,161 | 226,812 (0%) | 0% | 13.9 | 806,693 | Class A Common Stock |
| Aurinia Pharma Inc | Stephen P. Robertson | EVP, General Counsel | Sale of securities on an exchange or to another person at price $ 7.92 per share. | 28 Feb 2025 | 57,607 | 509,276 (0%) | 0% | 7.9 | 456,247 | Common Stock |
| QuantumScape Corp (Class A) | Michael O. McCarthy | CHIEF LEGAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 56,827 | 1,067,350 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Timothy Holme | CHIEF TECHNOLOGY OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 56,827 | 1,125,708 | - | 0 | Class A Common Stock | |
| QuantumScape Corp (Class A) | Mohit Singh | CHIEF DEVELOPMENT OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 56,827 | 1,022,372 | - | 0 | Class A Common Stock | |
| Fidelity National Information | James Kehoe | EVP, Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 56,318 | 56,318 | - | - | Restricted Stock Units | |
| Aurinia Pharma Inc | Joseph M. Miller | Chief Financial Officer | 28 Feb 2025 | 56,154 | 577,361 (0%) | 0% | 7.9 | 444,740 | Common Stock | |
| ARKO Corp (Class A) | Arie Kotler | Director, Chairman, President and CEO, Ten Percent Owner | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.51 per share. | 28 Feb 2025 | 55,833 | 11,945,444 | - | 4.5 | 251,807 | Common Stock, par value $0.0001 per share |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 16.21 per share. | 28 Feb 2025 | 55,750 | 147,941 (0%) | 0% | 16.2 | 903,462 | Ordinary Shares |
| Upstart Holdings Inc | Sanjay Datta | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,728 | 55,728 | - | - | Employee Stock Option (Right to buy) | |
| Upstart Holdings Inc | Paul Gu | Director, Chief Technology Offier | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,728 | 55,728 | - | - | Employee Stock Option (Right to buy) | |
| Moderna | Shannon Thyme Klinger | Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,543 | 55,543 | - | - | Stock Option (Right to Buy) | |
| Dave Inc (Class A) | Jason Wilk | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 100.66 per share. | 28 Feb 2025 | 55,066 | 196,382 | - | 100.7 | 5,542,944 | Class A Common Stock |
| CVRx Inc | Robert Allen John | Chief Revenue Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 55,000 | 55,000 | - | 0 | Common Stock | |
| United Airlines Holdings | Brett J. Hart | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 54,631 | 54,631 | - | - | Restricted Stock Units | |
| QuantumScape Corp (Class A) | Kevin Hettrich | CHIEF FINANCIAL OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 54,321 | 985,121 | - | 0 | Class A Common Stock | |
| The Baldwin Insurance Grp Inc (Class A) | Trevor L. Baldwin | Director, Chief Executive Officer, Member of 10% Owner Group | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 54,290 | 170,766 (0%) | 0% | 0 | Class A Common Stock | |
| Goodyear Tire & Rubber Co. | Christopher R. Delaney | President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 54,228 | 233,010 (0%) | 0% | 0 | Common Stock | |
| Goodyear Tire & Rubber Co. | Christopher R. Delaney | President, EMEA | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 54,228 | 0 | - | - | 2017 Plan Restricted Stock Units | |
| Inogen Inc | Kevin R. M. Smith | Director, CEO and President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 53,975 | 84,662 (0%) | 0% | 0 | Common Stock | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 53,419 | 0 | - | - | Restricted Stock Units | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 53,419 | 657,089 (0%) | 0% | 0 | Common Stock | |
| Occidental Petroleum | Sylvia J. Kerrigan | SVP & Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 53,236 | 154,161 (0%) | 0% | 0 | Common Stock | |
| Public Service Enterprise | Ralph A. Larossa | Director, Chair, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 81.04 per share. | 28 Feb 2025 | 52,526 | 224,425 (0%) | 0% | 81.0 | 4,256,707 | Common Stock |
| Viavi Soln Inc | Oleg Khaykin | Director, President & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.18 per share. | 28 Feb 2025 | 52,492 | 1,701,068 (0%) | 0% | 11.2 | 586,861 | Common Stock |
| Warner Bros. (Class A) | Lori C. Locke | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 52,357 | 150,084 (0%) | 0% | 0 | Series A Common Stock | |
| TransUnion | Tiffani Chambers | EVP, Chief Operations Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 52,321 | 62,329 (0%) | 0% | 0 | Common Stock | |
| Lexicon Pharma Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 52,317 | 104,633 | - | - | Restricted Stock Units | |
| Lexicon Pharma Inc | Wendy E. McDermott | SVP, Human Resources | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 52,317 | 151,650 (0%) | 0% | - | Common Stock | |
| NuScale Power Corp (Class A) | Carl Fisher | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 52,083 | 104,167 | - | - | Restricted Stock Unit | |
| NuScale Power Corp (Class A) | Carl Fisher | Chief Operating Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 52,083 | 82,406 | - | 0 | Class A Common Stock | |
| Brandywine Realty Trust | Shawn Neuman | General Counsel & Secretary | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,947 | 175,117 (0%) | 0% | 0 | Common Shares of Beneficial Interest | |
| Fortive | Olumide Soroye | President & CEO of AHS and IOS | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,890 | 51,890 | - | - | Employee Stock Option (Right to Buy) | |
| Applovin Corp (Class A) | Herald Y. Chen | Director | Sale of securities on an exchange or to another person at price $ 325.87 per share. | 28 Feb 2025 | 51,831 | 654,974 | - | 325.9 | 16,890,168 | Class A Common Stock |
| GoDaddy | Mark McCaffrey | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,728 | 149,736 (0%) | 0% | 0 | Class A Common Stock | |
| GoDaddy | Roger Chen | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,728 | 258,949 (0%) | 0% | 0 | Class A Common Stock | |
| Criteo S.A (ADR) | Michael Komasinski | Director, CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,635 | 51,635 (0%) | 0% | 0 | Ordinary Shares | |
| Lincoln Educational Services Corp | John A. Bartholdson | Director, Chairman | Sale of securities on an exchange or to another person at price $ 18.50 per share. | 28 Feb 2025 | 51,506 | 150,000 (0%) | 0% | 18.5 | 952,861 | Common Stock, no par value per share |
| Equitable Holdings Inc | Jeffrey J. Hurd | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 51,096 | 140,834 (0%) | 0% | 0 | Common Stock | |
| Inogen Inc | Michael Bourque | EVP, CFO & Treasurer | 28 Feb 2025 | 51,020 | 51,020 | - | - | Restricted Stock Unit | ||
| American Airlines Grp Inc | Robert D. Isom | Director, CEO and President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 14.35 per share. | 28 Feb 2025 | 50,854 | 3,548,356 (0%) | 0% | 14.4 | 729,755 | Common Stock |
| Kimberly-Clark | Michael D. Hsu | Director, Chairman of the Board and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 142.01 per share. | 28 Feb 2025 | 50,575 | 253,308 (0%) | 0% | 142.0 | 7,182,156 | Common Stock |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,560 | 101,121 | - | - | Restricted Stock Units | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,560 | 757,210 (0%) | 0% | 0 | Common Stock | |
| Talen Energy Corp - Ordinary Shares New | Mark A. McFarland | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 50,344 | 50,344 | - | - | 2025 Performance-Based Restricted Stock Units | |
| Lam Research | Douglas R. Bettinger | Chief Financial Officer & EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 50,153 | 50,153 | - | - | Market-based Performance Restricted Stock Unit | |
| Safehold Inc | Jay Sugarman | Director, CHAIRMAN AND CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 28 Feb 2025 | 50,010 | 1,828,548 (3%) | 0% | 0 | Common Stock | |
| Clear Channel Outdoor Holdings Inc | Scott R. Wells | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.26 per share. | 28 Feb 2025 | 50,000 | 3,525,144 (6%) | 0% | 1.3 | 63,000 | Common Stock |
| Lightwave Logic Inc | Siraj Nour El-Ahmadi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 670,000 | - | - | Employee Stock Option (Right to Buy) | |
| Lightwave Logic Inc | Siraj Nour El-Ahmadi | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.80 per share. | 28 Feb 2025 | 50,000 | 121,369 | - | 0.8 | 40,000 | Common Stock |
| Somnigroup Intl Inc | David Montgomery | EVP Global Business Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 63,384 | - | - | Stock Option (right to buy) | |
| Somnigroup Intl Inc | David Montgomery | EVP Global Business Strategy | Exercise or conversion of derivative security received from the company (such as an option) at price $ 17.38 per share. | 28 Feb 2025 | 50,000 | 908,624 (1%) | 0% | 17.4 | 869,000 | Common Stock |
| 10x Genomics Inc (Class A) | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 17,463 | - | - | Stock Option (right to buy) | |
| 10x Genomics Inc (Class A) | Serge Saxonov | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.20 per share. | 28 Feb 2025 | 50,000 | 921,540 (4%) | 0% | 1.2 | 60,000 | Class A Common Stock |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 28 Feb 2025 | 50,000 | 544,117 (1%) | 0% | 0.6 | 30,000 | American Depositary Shares |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.60 per share. | 28 Feb 2025 | 50,000 | 544,117 (1%) | 0% | 0.6 | 30,000 | American Depositary Shares |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 539,165 | - | - | Stock Options (Right to Buy) | |
| Zai Lab Ltd (ADR) | Samantha Du | Director, Chairperson & CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 50,000 | 489,165 | - | - | Stock Options (Right to Buy) | |
| SPX Tech Inc | Eugene Joseph Lowe | Director, PRESIDENT AND CEO | Sale of securities on an exchange or to another person at price $ 145.27 per share. | 28 Feb 2025 | 49,900 | 793,341 (1%) | 0% | 145.3 | 7,248,973 | Common Stock |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 49,800 | 99,602 | - | - | Restricted Share Units | |
| Teva- pharma Ind Ltd (ADR) | Eli Kalif | EVP, Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 49,800 | 197,741 (0%) | 0% | - | Ordinary Shares | |
| Leggett & Platt Inc | J. Tyson Hagale | EVP, Pres. - Bedding Products | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 49,597 | 134,067 (0%) | 0% | 0 | Common Stock | |
| Leggett & Platt Inc | Benjamin M. Burns | Executive Vice President - CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Feb 2025 | 49,597 | 133,184 (0%) | 0% | 0 | Common Stock | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 49,561 | 49,561 | - | - | Restricted Stock Units | |
| United Airlines Holdings | J. Scott Kirby | Director, Chief Executive Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 28 Feb 2025 | 49,561 | 706,650 (0%) | 0% | 0 | Common Stock |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.